These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34956321)

  • 21. Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma.
    Li J; Li H; Zhang C; Zhang C; Jiang L; Wang H; Liu H
    Front Oncol; 2021; 11():732841. PubMed ID: 34631565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.
    Huang H; Shi Z; Li Y; Zhu G; Chen C; Zhang Z; Shi R; Su L; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
    Front Oncol; 2022; 12():850943. PubMed ID: 35311148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma.
    Li N; Su M; Zhu L; Wang L; Peng Y; Dong B; Ma L; Liu Y
    Int J Gen Med; 2021; 14():8955-8974. PubMed ID: 34866936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma.
    Wan R; Bai L; Cai C; Ya W; Jiang J; Hu C; Chen Q; Zhao B; Li Y
    Comput Struct Biotechnol J; 2021; 19():6386-6399. PubMed ID: 34938414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Pan J; Huang Z; Xu Y
    Front Cell Dev Biol; 2021; 9():671821. PubMed ID: 34268304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A five-long non-coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma.
    Zeng L; Wang W; Chen Y; Lv X; Yuan J; Sun R; Yang S
    Exp Ther Med; 2019 Dec; 18(6):4852-4864. PubMed ID: 31777562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma.
    Fei X; Hu C; Wang X; Lu C; Chen H; Sun B; Li C
    Front Cell Dev Biol; 2021; 9():751490. PubMed ID: 34820377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics algorithm for lung adenocarcinoma based on macropinocytosis-related long noncoding RNAs as a reliable indicator for predicting survival outcomes and selecting suitable anti-tumor drugs.
    Chen H; Xu S; Hu Z; Wei Y; Zhu Y; Fang S; Pan Q; Liu K; Li N; Zhu L; Xu G
    Medicine (Baltimore); 2022 Sep; 101(38):e30543. PubMed ID: 36197217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
    Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
    J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M; Liu B; Xiao J; Yang Y; Zhang Y
    Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.
    Guo D; Wang M; Shen Z; Zhu J
    J Transl Med; 2020 Mar; 18(1):123. PubMed ID: 32143735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
    Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
    J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
    Zheng Y; Tian H; Zhou Z; Xiao C; Liu H; Liu Y; Wang L; Fan T; Zheng B; Tan F; Xue Q; Gao G; Li C; He J
    Front Cell Dev Biol; 2021; 9():651406. PubMed ID: 33816503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.
    Jiang X; Gao Y; Zhang N; Yuan C; Luo Y; Sun W; Zhang J; Ren J; Gong Y; Xie C
    Cell Transplant; 2020; 29():963689720977131. PubMed ID: 33334139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.